Khalid Ibrahim D, Akram Yahya N. Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor. Iraqi J. Pharm. [Internet]. 2023 Dec. 1 [cited 2025 Sep. 27];20(2):168-73. Available from: https://jwups.uomosul.edu.iq/index.php/iphr/article/view/40453